Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas Van Baren, Patrick Weynants, Vincent Brichard, Brigitte Dréno, Marie Hélène Tessier, Elaine Rankin, Giorgio Parmiani, Flavio Arienti, Yves Humblet, André Bourlond, Romain Vanwijck, Danielle Liénard, Marc Beauduin, Pierre Yves Dietrich, Vincenzo Russo, Joseph Kerger, Giuseppe Masucci, Elke Jäger, Jacques De GreveJens Atzpodien, Francis Brasseur, Pierre G. Coulie, Pierre Van Der Bruggen, Thierry Boon

Research output: Contribution to journalArticle

Abstract

Thirty-nine tumor-bearing patients with metastatic melanoma were treated with 3 subcutaneous injections of the MAGE-3.A1 peptide at monthly intervals. No significant toxicity was observed. Of the 25 patients who received the complete treatment, 7 displayed significant tumor regressions. All but one of these regressions involved cutaneous metastases. Three regressions were complete and 2 of these led to a disease-free state, which persisted for more than 2 years after the beginning of treatment. No evidence for a cytolytic T lymphocyte (CTL) response was found in the blood of the 4 patients who were analyzed, including 2 who displayed complete tumor regression. Our results suggest that injection of the MAGE-3.A1 peptide induced tumor regression in a significant number of the patients, even though no massive CTL response was produced.

Original languageEnglish
Pages (from-to)219-230
Number of pages12
JournalInternational Journal of Cancer
Volume80
Issue number2
DOIs
Publication statusPublished - Jan 18 1999

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1'. Together they form a unique fingerprint.

  • Cite this

    Marchand, M., Van Baren, N., Weynants, P., Brichard, V., Dréno, B., Tessier, M. H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck, R., Liénard, D., Beauduin, M., Dietrich, P. Y., Russo, V., Kerger, J., Masucci, G., Jäger, E., ... Boon, T. (1999). Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. International Journal of Cancer, 80(2), 219-230. https://doi.org/10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S